Shaoyan Xi - Concepedia

Author

Shaoyan Xi

Sun Yat-sen University ORCID

Also Known As

S.Y. Xi, Shao-Yan Xi, Shao-yan Xi, ShaoYan Xi, Shaoyan Xi, Shao‐Yan Xi, Xi Shaoyan, Xi, Shao-Yan, Xi, Shaoyan, s xi

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Sun Yat-sen University Sun Yat-sen University Cancer Center State Key Laboratory of Oncology in South China Guangzhou Medical University Sun Yat-sen Memorial Hospital

About

Shaoyan Xi is an author at Sun Yat-sen University specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	558
2	Health Sciences	5	5	132
3	Cell Biology	5	5	225
4	Gastroenterology	2	2	126
5	Hepatology	2	2	56

Shaoyan Xi

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Interrogating glioma-M2 macrophage interactions identifies Gal-9/Tim-3 as a viable target against <i>PTEN</i> -null glioblastoma Xiangrong Ni, Wei-Chi Wu, Xiaoqiang Sun, Science Advances	2022	123
Microrna-124 targets flotillin-1 to regulate proliferation and migration in breast cancer Laisheng Li, Jinmei Luo, Bo Wang, Molecular Cancer	2013	115
Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial Shuqiang Yuan, Run‐Cong Nie, Ying Jin, Nature Medicine Esophageal CancerGastrointestinal OncologyMedicineGastroenterologyPerioperative Toripalimab	2024	97
Targeted Expression of miR-34a Using the T-VISA System Suppresses Breast Cancer Cell Growth and Invasion Laisheng Li, Xinhua Xie, Jinmei Luo, Molecular Therapy	2012	95
LncRNA LINC00998 inhibits the malignant glioma phenotype via the CBX3-mediated c-Met/Akt/mTOR axis Haiping Cai, Yanjiao Yu, Xiangrong Ni, Cell Death and Disease Glioma ProgressionMalignant Glioma PhenotypeCancer BiologyGliomaTumor Biology	2020	87
Targeting tumor lineage plasticity in hepatocellular carcinoma using an anti-CLDN6 antibody-drug conjugate Fan-En Kong, Guangmeng Li, Yunqiang Tang, Science Translational Medicine	2021	66
Overexpression of LAMC1 predicts poor prognosis and enhances tumor cell invasion and migration in hepatocellular carcinoma Yaojun Zhang, Shaoyan Xi, Jinbin Chen, Journal of Cancer	2017	65
Diagnostic performance of multiparametric MRI in the evaluation of treatment response in glioma patients at 3T Jie Liu, Cong Li, Yinsheng Chen, Journal of Magnetic Resonance Imaging	2019	52
Downregulation of EIF4A2 in Non–Small-Cell Lung Cancer Associates with Poor Prognosis Shaoyan Xi, Juanjuan Yong, Ya-Lan Tao, Clinical Lung Cancer MedicineCancer Cell BiologyPathologyCancer BiologyPoor Prognosis	2013	42
Elevated expression of RIT1 hyperactivates RAS/MAPK signal and sensitizes hepatocellular carcinoma to combined treatment with sorafenib and AKT inhibitor Liang-Zhan Sun, Shaoyan Xi, Zhengdong Zhou, Oncogene Ras/mapk SignalOncologyElevated ExpressionMedicineLiver Physiology	2021	42

Page 1